Vitamin D deficiency is associated with inflammatory cytokine concentrations in patients with diabetic foot infection

British Journal of Nutrition

Volumn 112, Issue 12, 2014, Pages 1938-1943

  Tiwari, Shalbha ^a,b   Pratyush, Daliparthy Devi ^a,c   Gupta, Sanjeev Kumar ^a   Singh, Surya Kumar ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b Chellaram Diabetes Institute   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Diabetic foot infection; Inflammatory cytokines; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; GAMMA INTERFERON; HEMOGLOBIN A1C; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; 25-HYDROXYVITAMIN D; AUTACOID; CYTOKINE; VITAMIN D;

ADULT; AGE; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC FOOT; DISEASE DURATION; ESCHERICHIA COLI; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROTEIN BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; COMPLICATION; FOOT; INFECTION; INFLAMMATION;

CASE-CONTROL STUDIES; CYTOKINES; DIABETES MELLITUS; DIABETIC FOOT; FEMALE; FOOT; HUMANS; INFECTION; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84915782202     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114514003018     Document Type: Article

References (33)

1. Helming L, Bose J & Ehrchen J (2005) 1a,25-DihydroxyvitaminD3 is a potent suppressor of interferon g-mediatedmacrophage activation. Blood 106, 4351-4358.
2. Van EE & Mathieu C (2005) Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Ster Biochem MolBiol 97, 93-101.
3. James RS, Paolo DP, Ralph JC, et al. (2010) Serum 25-hydroxyvitaminD and the incidence of acute viral respiratory tractinfections in healthy adults. PLoS ONE 5, 11088.
4. Goswami R, Gupta N, Goswami D, et al. (2000) Prevalenceand significance of low 25-hydroxyvitamin D concentrationsin healthy subjects in Delhi. Am J Clin Nutr 72, 472-475.
5. Singh SK, Prakash V, Tiwari S, et al. (2011) Summer andwinter prevalence of vitamin D deficiency of young residentdoctors in North India. Nutr Diet 68, 280-284.
6. Mattila C, Knekt P, Mannisto S, et al. (2007) Serum 25-hydroxyvitaminD concentration and subsequent risk of type 2diabetes. Diabetes Care 30, 2569-2570.
7. Iacopino AM (1995) Diabetic periodontitis: possible lipidinduceddefect in tissue repair through alteration of macrophagephenotype and function. Oral Dis 1, 214-229.
8. Oncul O, Yildiz S, Gurer US, et al. (2007) Effect of the functionof polymorphonuclear leukocytes and interleukin-1b onwound healing in patients with diabetic foot infections.J Infect 54, 250-256.
9. Galkowska H, Wojewodzka U & Olszewski WL (2006)Chemokines, cytokines, and growth factors in keratinocytesand dermal endothelial cells in the margin of chronicdiabetic foot ulcers. Wound Repair Regen 14, 558-565.
10. Goren I, Muller E, Pfeilschifter J, et al. (2006) Severelyimpaired insulin signaling in chronic wounds of diabeticob/ob mice: a potential role of tumor necrosis factor-a.Am J Pathol 168, 765-777.
11. Falanga V (2005) Wound healing and its impairment in thediabetic foot. Lancet 366, 1736-1743.
12. Geerlings SE & Hoepelman AIM (1999) Immune dysfunctionin patients with diabetes mellitus (DM). FEMS Immunol MedMicrobiol 26, 259-265.
13. Kazuichi M, Jun A, Masaaki I, et al. (2007) Decreased macrophagenumber and activation lead to reduced lymphaticvessel formation and contribute to impaired diabetic wouldhealing. Am J Pathol 170, 1178-1191.
14. Galiano RD, Tepper OM, Pelo CR, et al. (2004) Topical vascularendothelial growth factor accelerates diabetic woundhealing through increased angiogenesis and by mobilizingand recruiting bone marrow-derived cells. Am J Pathol164, 1935-1947.
15. Peleg AY, Weerarathna T, McCarthy JS, et al. (2007) Commoninfections in diabetes: pathogenesis, management andrelationship to glycaemic control. Diabetes Metab Res Rev23, 3-13.
16. Naguib G, Al-Mashat H, Desta T, et al. (2004) Diabetes prolongsthe inflammatory response to a bacterial stimulusthrough cytokine dysregulation. J Investig Dermatol 123,87-92.
17. Geerlings S, Brouwer E, Van KK, et al. (2000) Cytokinesecretion is impaired in women with diabetes mellitus. EurJ Clin Invest 30, 995-1001.
18. Mishima Y, Kuyanma A, Tada A, et al. (2001) Relationshipbetween serum tumor necrosis factor- A and insulin resistancein obese men with type 2 diabetes mellitus. DiabetesRes Clin Pract 52, 119-123.
19. Brem H & Tomic-Canic M (2007) Cellular and molecularbasis of wound healing in diabetes. J Clin Invest 117,1219-1222.
20. Agren MS, Eaglstein WH, Ferguson MW, et al. (2000) Causesand effects of the chronic inflammation in venous leg ulcers.Acta Derm Venereol 210, 3-17.
21. Tiwari S, Pratyush DD, Gupta B, et al. (2013) Prevalence andseverity of vitamin D deficiency in patients with diabetic footinfection. Br J Nutr 109, 99-102.
22. Tiwari S, Pratyush DD, Dwivedi A, et al. (2012) Microbiologicaland clinical characteristics of diabetic foot infections innorthern India. J Infect Dev Ctries 6, 329-332.
23. Holick MF, Binckley NC, Bischoff-Ferrari HA, et al. (2011)Evaluation, treatment, and prevention of vitamin Ddeficiency: an Endocrine Society Clinical Practice Guideline.J Clin Endocrinol Metab 96, 1911-1930.
24. Weigelt C, Rose B, Poschen U, et al. (2009) Immunemediators in patients with acute diabetic foot syndrome.Diabetes Care 32, 1491-1496.
25. Himmerich H, Fulda S, Linseisen J, et al. (2006) TNF-a,soluble TNF receptor and interleukin-6 plasma levels in thegeneral population. Eur Cytokine Netw 17, 196-201.
26. U.K. Prospective Diabetes Study Group (1995) U.K. ProspectiveDiabetes Study 16-overview of 6 years' therapy of typeII diabetes: a progressive disease. Diabetes 44, 1249-1258.
27. Maedler K, Sergeev P, Ris F, et al. (2002) Glucose-inducedb-cell production of IL-1b contributes to glucotoxicity inhuman pancreatic islets. J Clin Invest 110, 851-860.
28. Giulietti A, Etten EV, Overbergh LK, et al. (2007) Monocytesfrom type 2 diabetic patients have a pro-inflammatory pro-file. 1,25-Dihydroxyvitamin D3 works as anti-inflammatory.Diabetes Res Clin Pract 77, 47-57.
29. Schleithoff SS, Zittermann A, Tenderich G, et al. (2006)Vitamin D supplementation improves cytokine profiles inpatients with congestive heart failure: a double-blind,randomized, placebo-controlled trial. Am J Clin Nutr 83,754-759.
30. Clendenen TV, Koenig KL, Arslan AA, et al. (2011) Factorsassociated with inflammation markers, a cross-sectionalanalysis. Cytokine 56, 769-778.
31. Harinarayan CV, Holick MF, Prasad UV, et al. (2013) VitaminD status and sun exposure in India. Dermato-Endocrinology5, 130-141.
32. McCarty CA (2008) Sunlight exposure assessment: can weaccurately assess vitamin D exposure from sunlight questionnairesAm J Clin Nutr 87, 1097S-1101S.
33. Conesa-Botella A, Meintjes G, Coussens AK, et al. (2012)Corticosteroid therapy, vitamin D status, and inflammatorycytokine profile in the HIV-tuberculosis immune reconstitutioninflammatory syndrome. Clin Infect Dis 55, 1004-1011.